Searched for
US HEPATITIS
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...- GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studiesGSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Louisiana primary election results, winners: Can sitting Republican Senator Bill Cassidy win against Donald Trump-backed candidate Julia Letlow?Bill Cassidy Louisiana primary election results: Republican Senator's vote in favor of convicting Donald Trump after his 2021 impeachment o...
- Evidence confirms U.S. newborn Hepatitis B vaccination policy amid calls to delayAn independent review of more than 400 studies confirms that the U.S. policy of providing the hepatitis B vaccine to newborns has reduced c...
- Is Hepatitis A dangerous? Here is everything you need to know about Hepatitis AIndia has a high number of chronic Hepatitis B and C cases, while Hepatitis A can lead to acute liver failure, it is usually a short-term i...
- 10 Celebrities With Hepatitis C10 Celebrities With Hepatitis C
- Children in US in danger of Pediatric Hepatitis, doctors warnedAdenovirus can cause serious illnesses in people with a weak immune system. People with cardiac problems or respiratory diseases could also...
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- Tata Trusts, Gilead sign MoU on viral hepatitis in IndiaUnder the MoU, companies will form a joint program committee to implement activities related to prevention, awareness and education, testin...
- Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- New medicine for Hepatitis C treatment launchedDuring the conference, two new drugs were launched for treatment of Hepatitis C disease at affordable price.
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Hepatitis C infection may fuel heart disease riskPeople infected with HIV are already known to have an elevated risk for heart disease but hepatitis C can spark cardiovascular damage indep...
- Rs 2,277 drug can treat hepatitis B patientsHepatitis B is transmitted through blood and infected bodily fluids. There is also a risk of infected mothers passing on the Hepatitis B vi...
- Cipla to launch generic Hepatitis C drug 'Hepcvir' in IndiaThe availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said.
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Cure for Hepatitis C in HIV patients on the cardsApproximately one-third of HIV patients in the US have hepatitis C, with an estimated 7 million co-infected patients worldwide.
- New drug combo cures toughest cases of hepatitis CResults were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.
Load More
